U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Jane Street Group LLC

Jane Street Group LLC lowered its stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 45.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 14,118 shares of the company's stock after selling 11,800 shares during the quarter. Jane Street Group LLC owned 0.09% of U.S. Physical Therapy worth $1,252,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Wells Fargo & Company MN boosted its position in U.S. Physical Therapy by 2.2% during the fourth quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock worth $10,021,000 after acquiring an additional 2,465 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of U.S. Physical Therapy by 37.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company's stock worth $409,000 after purchasing an additional 1,254 shares during the last quarter. Copeland Capital Management LLC grew its position in shares of U.S. Physical Therapy by 9.5% in the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after purchasing an additional 72,715 shares in the last quarter. Proficio Capital Partners LLC acquired a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at approximately $3,526,000. Finally, Bridge City Capital LLC lifted its position in U.S. Physical Therapy by 7.0% during the fourth quarter. Bridge City Capital LLC now owns 64,947 shares of the company's stock worth $5,761,000 after buying an additional 4,235 shares in the last quarter.

U.S. Physical Therapy Stock Down 1.9%

Shares of USPH traded down $1.44 during mid-day trading on Monday, hitting $73.96. 107,229 shares of the company's stock were exchanged, compared to its average volume of 111,709. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $102.89. The company has a market cap of $1.12 billion, a price-to-earnings ratio of 78.68, a P/E/G ratio of 3.54 and a beta of 1.44. The stock's 50-day moving average is $71.85 and its 200-day moving average is $83.05.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. The firm had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm's revenue was up 18.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.51 earnings per share. On average, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.43%. The ex-dividend date is Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 82.57%.

Insiders Place Their Bets

In related news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. The trade was a 19.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 2.00% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

USPH has been the subject of a number of recent research reports. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. JMP Securities restated a "market outperform" rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. JPMorgan Chase & Co. dropped their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Wednesday, March 19th. Finally, Barrington Research decreased their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, U.S. Physical Therapy presently has a consensus rating of "Moderate Buy" and an average target price of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.